Area served Worldwide Website www.metamed.com Founded 2012 | Industry Managed health care Headquarters New York City Defunct 2015 | |
 | ||
Products Personalized medical research | ||
Google hangout and q a with brenda mathisen of metamed
MetaMed Research was a medical consulting firm aiming to provide high-end personalized medical research services. It was founded in 2012 by Michael Vassar (previously of the Singularity Institute), Jaan Tallinn (co-founder of Skype and Kazaa), and Zvi Mowshowitz, with startup funding from Silicon Valley investor Peter Thiel. Metamed stated that its researchers were drawn from top universities, as well as prominent technology companies such as Google.
Contents
- Google hangout and q a with brenda mathisen of metamed
- Jaan tallinn discusses deepmind metamed
- Concept
- Services
- Termination
- References
Jaan tallinn discusses deepmind metamed
Concept
Vassar founded MetaMed to apply the principles of rationality as taught by Eliezer Yudkowsky to medicine, having left Yudkowsky's Singularity Institute to do so. MetaMed was designed provide an alternative to typical healthcare by providing higher quality research. Vassar explained,
We can save lots and lots and lots of lives. But it’s the signal — it's the "Hey! Reason works!" — that matters. It's not really about medicine.
Services
Company researchers gathered detailed medical information on each client, using this as the basis for the creation of personalized research reports for various conditions (or, in some cases, for the purpose of client performance enhancement). It also assessed the expected value of various tests, and created maps of correlations between possible medical conditions. One aim of the company was to aid doctors with advanced artificial intelligence and data from information experts.
MetaMed's personalized medical research services were targeted at the market for concierge medicine, with prices ranging from a few thousand dollars to hundreds of thousands. One patient, who had been provided free services by MetaMed, said that personalized medical research was the "only thing that has helped him" after seeing numerous doctors.
Termination
By 2015, MetaMed was defunct, which Tallinn attributed to the difficulty of producing research results and limited interest from consumers.